Related Experiment Video
Updated: May 26, 2026
07:27
Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty
Published on: October 6, 2016
Epilepsy in the elderly and depression
Dubravka Sepić Grahovac1, Klementina Ruzić, Tanja Grahovac
1Polyclinic for Neurology and Psychiatry "Interneuron", Rijeka, Croatia. poliklinika.interneuron@ri.t-com.hr
Collegium Antropologicum
|January 7, 2012
Summary
This study investigated epilepsy and depression in 83 patients, finding new antiepileptic drugs effectively reduce seizures and mental health issues in geriatric epilepsy patients.
Area of Science:
- Neurology
- Geriatrics
- Psychiatry
Background:
- Epilepsy affects 1% of the global population, with higher rates in the elderly.
- Depression is a frequent comorbidity in epilepsy patients.
- Limited research exists on depression within geriatric epilepsy populations.
Purpose of the Study:
- To analyze the impact of antiepileptic and antipsychotic drugs on geriatric epilepsy patients with mental disorders.
- To evaluate the efficacy of new antiepileptic drugs in managing seizures and psychiatric symptoms.
Main Methods:
- Analysis of 83 patients with epilepsy phenotypes and mental disorders.
- Evaluation of antiepileptic and antipsychotic drug treatments.
- Assessment of both monotherapy and polytherapy regimens.
Main Results:
- Newer antiepileptic drugs showed positive effects in managing epilepsy.
- These new medications also demonstrated efficacy in reducing mental disorders, including depression.
- Both monotherapy and polytherapy approaches were evaluated.
Conclusions:
- Newer antiepileptic drugs offer a dual benefit for geriatric epilepsy patients with depression.
- Treatment strategies involving modern antiepileptics can improve seizure control and mental well-being.
- Further research into geriatric epilepsy comorbidities is warranted.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
01:22Epilepsy ll: Types
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...